Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]
EMERGING TESTS
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
February 18, 2019
TESTING STRATEGY
PreOp Point-of-Care HbA1c Screening May Cut Complications
February 11, 2019
Point-of-care (POC) HbA1c measurements show a high level of agreement with central laboratory test in the outpatient setting, according to a small study published Jan. 18 in the Journal of Clinical … [Read more...]
INDUSTRY TRENDS
Point-of-Care PCR Tests Better Diagnosis, Rx for Kids’ Sore Throats
February 5, 2019
Given we are still in the midst of cold and flu season, a new study highlights the benefit of point-of-care (POC) polymerase chain reaction (PCR) testing among pediatric patients presenting to the … [Read more...]
INDUSTRY TRENDS
Diagnostics Sector Saw Increased Investment, Exits in 2018
January 28, 2019
Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]
EMERGING TESTS
Sequencing Shows Promise in Care of Common Kidney Disease
January 22, 2019
Exome sequencing can yield a genetic diagnosis in almost 10 percent of patients with chronic kidney disease (CKD), according to a study published Jan. 10 in the New England Journal of Medicine. This … [Read more...]
PRECISION MEDICINE
Newborn Sequencing Delivers Some Unanticipated Findings
January 22, 2019
Newborn genomic sequencing (NGS) can identify risk for a wide range of disorders that otherwise may not be detected, even in seemingly healthy babies, according to a study published Jan. 3 in the … [Read more...]
THE BUSINESS OF TESTING
Payer Medical Policies Can Promote Effective Use of Comprehensive Sequencing In Community Oncology Setting
January 22, 2019
Comprehensive genomic profiling (CGP) identifies clinically relevant genomic alterations that can be used to inform treatment decisions in community-based oncology practices that benefit both patients … [Read more...]
TESTING TRENDS
Zika Blood Screening Not Cost-Effective, Study Finds
January 22, 2019
Screening blood donors for Zika virus is not cost-effective in the United States or Puerto Rico, according to a study published Jan. 8 in the Annals of Internal Medicine. Despite U.S. Food and Drug … [Read more...]
TESTING TRENDS
Low-Value, Blood Glucose Self-Monitoring is Common
January 21, 2019
A substantial percentage of patients with type 2 diabetes may be inappropriately self-monitoring blood glucose, according to a research letter published Dec. 10 in JAMA Internal Medicine. Despite … [Read more...]
EMERGING TESTS
Cytokines Could Predict Risk of Side Effects From Immunotherapy
January 14, 2019
Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to a pilot study published Oct. 31 in the British … [Read more...]
